Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes

NCT02928250 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT02928250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02928250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
Not reported
Enrollment
90 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carnosine, diabetic nephropathy, oxidative stress, type 1 diabetes